GLUL and Alzheimer disease: It was reported that glutamatergic neurotransmission was severely disrupted in the brains of individuals with AD [26], especially in the hippocampus and neocortex, where the activities of glutamine synthetase and glutamate transporter were found to be significantly decreased [27].